JP2002533434A5 - - Google Patents

Download PDF

Info

Publication number
JP2002533434A5
JP2002533434A5 JP2000590994A JP2000590994A JP2002533434A5 JP 2002533434 A5 JP2002533434 A5 JP 2002533434A5 JP 2000590994 A JP2000590994 A JP 2000590994A JP 2000590994 A JP2000590994 A JP 2000590994A JP 2002533434 A5 JP2002533434 A5 JP 2002533434A5
Authority
JP
Japan
Prior art keywords
phenyl
carbonyl
ethenyl
sulfide
nitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000590994A
Other languages
English (en)
Japanese (ja)
Other versions
JP4057244B2 (ja
JP2002533434A (ja
Filing date
Publication date
Priority claimed from US09/222,491 external-priority patent/US6110922A/en
Application filed filed Critical
Publication of JP2002533434A publication Critical patent/JP2002533434A/ja
Publication of JP2002533434A5 publication Critical patent/JP2002533434A5/ja
Application granted granted Critical
Publication of JP4057244B2 publication Critical patent/JP4057244B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000590994A 1998-12-29 1999-12-29 細胞接着阻害抗炎症および免疫抑制化合物 Expired - Fee Related JP4057244B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/222,491 1998-12-29
US09/222,491 US6110922A (en) 1998-12-29 1998-12-29 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
PCT/US1999/031162 WO2000039081A2 (en) 1998-12-29 1999-12-29 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds

Publications (3)

Publication Number Publication Date
JP2002533434A JP2002533434A (ja) 2002-10-08
JP2002533434A5 true JP2002533434A5 (https=) 2006-01-05
JP4057244B2 JP4057244B2 (ja) 2008-03-05

Family

ID=22832440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000590994A Expired - Fee Related JP4057244B2 (ja) 1998-12-29 1999-12-29 細胞接着阻害抗炎症および免疫抑制化合物

Country Status (29)

Country Link
US (2) US6110922A (https=)
EP (1) EP1140814B1 (https=)
JP (1) JP4057244B2 (https=)
KR (1) KR100640984B1 (https=)
CN (3) CN1192018C (https=)
AT (1) ATE296283T1 (https=)
AU (1) AU771126B2 (https=)
BG (1) BG65177B1 (https=)
BR (1) BR9916638A (https=)
CA (1) CA2356320C (https=)
CZ (1) CZ296726B6 (https=)
DE (1) DE69925508T2 (https=)
EA (1) EA005207B1 (https=)
EE (1) EE200100355A (https=)
GE (1) GEP20043383B (https=)
HK (1) HK1041476B (https=)
HR (1) HRP20010512B1 (https=)
HU (1) HUP0200222A3 (https=)
IL (1) IL143968A0 (https=)
IS (1) IS5985A (https=)
MX (1) MXPA01006636A (https=)
NO (1) NO20013241L (https=)
NZ (1) NZ512687A (https=)
PL (1) PL195605B1 (https=)
SK (1) SK9402001A3 (https=)
UA (1) UA72909C2 (https=)
WO (1) WO2000039081A2 (https=)
YU (1) YU46701A (https=)
ZA (1) ZA200105344B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867203B2 (en) * 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
US6878700B1 (en) * 1998-12-29 2005-04-12 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
AU774054B2 (en) * 1999-04-02 2004-06-17 Icos Corporation Inhibitors of LFA-1 binding to ICAMs and uses thereof
UA74781C2 (en) * 1999-04-02 2006-02-15 Abbott Lab Antiinflammatory and immumosuppressive compounds inhibiting cell adhesion
WO2000060355A2 (en) * 1999-04-02 2000-10-12 Icos Corporation Lfa-1 regulatory binding site and uses thereof
NZ523445A (en) * 2000-06-29 2004-10-29 Abbott Lab Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
AU2001268724B2 (en) * 2000-06-29 2005-06-16 Abbott Laboratories Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
AU2002248142B2 (en) * 2000-11-28 2007-11-01 Genentech, Inc. LFA-1 antagonist compounds
AU2003203143B2 (en) * 2002-02-01 2009-05-14 High Point Pharmaceuticals, Llc Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
US7101898B2 (en) * 2002-02-01 2006-09-05 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
EP1546088B1 (en) * 2002-10-03 2014-12-17 Novaremed Ltd. Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
WO2004032861A2 (en) 2002-10-11 2004-04-22 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
GB0224917D0 (en) * 2002-10-25 2002-12-04 Novartis Ag Organic compounds
DE10258168B4 (de) * 2002-12-12 2005-07-07 Infineon Technologies Ag Integrierter DRAM-Halbleiterspeicher und Verfahren zum Betrieb desselben
CN1791592B (zh) * 2003-05-19 2012-07-04 Irm责任有限公司 免疫抑制剂化合物和组合物
JP2007186422A (ja) * 2004-01-28 2007-07-26 Astellas Pharma Inc アリールスルフィド誘導体
JP2007535555A (ja) * 2004-04-28 2007-12-06 イコス・コーポレイション 炎症性疾患および免疫疾患の処置に有用なアリールフェニルアミノ−およびアリールフェニルエーテル−スルフィド誘導体、およびそれらを含む医薬組成物
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
TW200616634A (en) 2004-10-01 2006-06-01 Bristol Myers Squibb Co Crystalline forms and process for preparing spiro-hydantoin compounds
US7186727B2 (en) 2004-12-14 2007-03-06 Bristol-Myers Squibb Company Pyridyl-substituted spiro-hydantoin compounds and use thereof
WO2013041621A1 (de) 2011-09-20 2013-03-28 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
JP6847799B2 (ja) * 2017-09-21 2021-03-24 株式会社東芝 二酸化炭素吸収剤及び二酸化炭素除去装置
EP4671235A1 (en) * 2024-06-26 2025-12-31 Oculis Operations Sàrl SYNTHESIS OF SMALL MOLECULE NEUROTROPHIN AGONISTS

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348142A (en) 1970-05-14 1974-03-13 Sandoz Ltd Derivatives of alpha-cyanacrylic acid their production and use as stabilizers for organic materials
JPS58146566A (ja) * 1982-02-24 1983-09-01 Maruko Seiyaku Kk ピリジン誘導体
JPS6212757A (ja) * 1985-07-10 1987-01-21 Yoshitomi Pharmaceut Ind Ltd 桂皮酸アミド誘導体
EP0219756B1 (de) 1985-10-09 1994-01-05 Shell Internationale Researchmaatschappij B.V. Neue Acrylsäureamide
US4973599A (en) 1989-03-14 1990-11-27 Hoffman-La Roche Inc. Phenylthioheterocyclic derivatives
US5028629A (en) 1990-03-28 1991-07-02 Eli Lilly And Company 5-Lipoxygenase inhibitors
US5208253A (en) 1992-02-24 1993-05-04 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo(b) thiophene-2-carboxamides as inhibitors of cell adhesion
JP3894949B2 (ja) 1993-06-30 2007-03-22 ザ、ウェルカム、ファンデーション、リミテッド 抗アテローム性動脈硬化症ジアリール化合物
DE4405830C2 (de) 1994-02-23 1995-11-30 Merck Patent Gmbh Verfahren zur Herstellung von Zimtsäure-Derivaten
US5883106A (en) 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
DE19527305A1 (de) 1995-07-26 1997-01-30 Hoechst Ag Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0887340A4 (en) * 1996-02-06 2000-03-29 Japan Tobacco Inc CHEMICAL COMPOUNDS AND THEIR PHARMACEUTICAL USE
US5912266A (en) 1996-08-21 1999-06-15 American Home Products Corporation Beta2 integrin cell adhesion molecule inhibitors
EP0942903A1 (en) 1996-09-26 1999-09-22 Novartis AG Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity
US5916916A (en) * 1996-10-10 1999-06-29 Eli Lilly And Company 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
PL336580A1 (en) 1997-03-03 2000-07-03 Boehringer Ingelheim Pharma Fine-molecular compounds useful in treating inflammatory diseases
JP2002501518A (ja) * 1997-05-30 2002-01-15 セルテック セラピューティックス リミテッド 抗炎症性チロシン誘導体
ES2306482T3 (es) 1997-08-28 2008-11-01 Novartis Ag Antagonistas de antigeno-1 funcion con funcion de linfocito.
WO1999020617A1 (en) 1997-10-21 1999-04-29 Active Biotech Ab Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
WO1999020618A1 (en) 1997-10-21 1999-04-29 Active Biotech Ab Thiadiazoles amides useful as antiinflammatory agents
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
HUP0101587A3 (en) 1998-03-27 2003-03-28 Genentech Inc Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
JP2000072766A (ja) 1998-08-27 2000-03-07 Dai Ichi Seiyaku Co Ltd ベンゾピラン誘導体
WO2000015645A1 (fr) 1998-09-11 2000-03-23 Kyorin Pharmaceutical Co., Ltd. Derives d'esters phosphoniques et leur procede de production
WO2000015604A1 (fr) 1998-09-11 2000-03-23 Kyorin Pharmaceutical Co., Ltd. Derives de diesters maloniques et leur procede d'obtention
US6331640B1 (en) 1998-10-13 2001-12-18 Hoffmann-La Roche Inc. Diaminopropionic acid derivatives
CO5140104A1 (es) 1999-02-16 2002-03-22 Novartis Ag Derivados de mevinolina y preparacion farmaceuticas que los contienen
EP1399155B1 (en) 1999-07-21 2008-05-28 Boehringer Ingelheim Pharmaceuticals Inc. Small molecules useful in the treatment of inflammatory disease
US6365615B1 (en) 1999-07-21 2002-04-02 Boehringer Ingelheim Pharmaceuticals, Inc. Small molecules useful in the treatment of inflammatory disease
ECSP003707A (es) 1999-10-13 2002-05-23 Novartis Ag Diazepanes

Similar Documents

Publication Publication Date Title
JP2002533434A5 (https=)
JP2004513063A5 (https=)
JP2004532886A5 (https=)
JP2008517945A5 (https=)
CN1993339B (zh) 芳香化合物
RU2475487C2 (ru) Имидазохинолины с иммуномодулирующими свойствами
ES2569327T3 (es) Promotores de la apoptosis que contienen N-acilsulfonamida
DE69429078T2 (de) Pharmacologisch wirksame pyridinderivate und verfahren zu deren herstellung
AU2003249962C1 (en) Inhibitors of tyrosine kinases
AU2008240804B2 (en) Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
RU2011127232A (ru) Апоптоз-индуцирующие средства для лечения рака и иммунных и аутоиммунных заболеваний
RU2007127834A (ru) Производные 1, 6-замещенного (3r, 6r)-3-(2, 3-дигидро-1н-инден-2-ил)-2, 5-пиперазиндиона в качестве антагонистов рецептора окситоцина для лечения преждевременных родов, дисменореи и эндометриоза
CA2479642A1 (en) 4-anilino quinazoline derivatives as antiproliferative agents
CA2995675C (en) Heteroaryl compounds and their use as therapeutic drugs
JP2004534010A5 (https=)
JP2003507328A5 (https=)
RU2004125146A (ru) Новые соединения
JP2013507449A5 (https=)
CA2396590A1 (en) 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
RU2003121018A (ru) Производные карбоксамида и их использование в лечении тромбоэмболических заболеваний и опухолей
RU2003100518A (ru) Производные бензотиазола
NO302473B1 (no) Pyrimidinderivater
RU2013133800A (ru) Селективные к bcl-2 агенты, вызывающие апоптоз, для лечения рака и иммунных заболеваний
KR20010013703A (ko) 피페라진 유도체 및 소염제로서의 그의 용도
JP2009528354A5 (https=)